Prostaglandin E2 Stimulates the Growth of Human Blood CD34 Progenitors
暂无分享,去创建一个
[1] V. Praloran,et al. Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. , 1997, Journal of lipid mediators and cell signalling.
[2] N. Nathan,et al. Eicosanoid and cytokine levels in plasma of patients during mesenteric infarction , 1997, Mediators of inflammation.
[3] F. Bertolini,et al. Functional and Morphological Characterization of Immunomagnetically Selected CD34+ Hematopoietic Progenitor Cells , 1996, Stem cells.
[4] Y. Denizot,et al. Human bone marrow fibroblasts--an overview of their characterization, proliferation and inflammatory mediator production. , 1996, Hematology and cell therapy.
[5] M. Fackler,et al. CD34: structure, biology, and clinical utility. , 1996, Blood.
[6] T. Luft,et al. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems , 1995, Stem cells.
[7] A. Thiel,et al. CD34+ human hemopoietic progenitor cells of the bone marrow differ from those of the peripheral blood: an immunocytochemical and morphometric study. , 1995, Acta haematologica.
[8] T. Holyoake,et al. CD34+ positive haemopoietic cells: biology and clinical applications. , 1994, Blood reviews.
[9] D. Bonnet,et al. Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. , 1993, Blood.
[10] H. Mayani,et al. Biology of the hemopoietic microenvironment , 1992, European journal of haematology.
[11] L. To,et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. , 1991, Blood.
[12] J. Falkenburg,et al. Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. , 1991, Lymphokine and cytokine research.
[13] V. Dzau,et al. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. , 1987, The American journal of cardiology.
[14] A. Miller,et al. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation. , 1986, Experimental hematology.
[15] P. Blackshear,et al. Plasma Level of 13,14-Dihydro-15-keto-PGE2 in Patients With Diabetic Ketoacidosis and in Normal Fasting Subjects , 1986, Diabetes.
[16] J. Desforges,et al. Lipoxygenase metabolites of arachidonic acid modulate hematopoiesis. , 1986, Blood.
[17] R. Taetle,et al. Abnormal modulation of granulocyte/macrophage progenitor proliferation by prostaglandin E in chronic myeloproliferative disorders. , 1980, Experimental hematology.
[18] W. Piacibello,et al. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1. , 1980, Cancer research.
[19] C. Peschle,et al. In vitro interactions of PGE and cAMP with murine and human erythroid precursors. , 1980, Blood.
[20] R. Taetle,et al. Effects of cyclic nucleotides and prostaglandins on normal and abnormal human myeloid progenitor proliferation. , 1980, Cancer Research.